Wang X, Pei D
Department of Pharmacology, University of Minnesota School of Medicine, Minneapolis, Minnesota 55455, USA.
J Biol Chem. 2001 Sep 21;276(38):35953-60. doi: 10.1074/jbc.M103680200. Epub 2001 Jul 26.
The shedding of membrane-associated proteins has been recognized as a regulatory mechanism to either up-regulate or down-regulate cellular functions by releasing membrane-bound growth factors or removing ectodomains of adhesion molecules and receptors. We have reported previously that the ectoenzyme of membrane type matrix metalloproteinase 5 (MT5-MMP) is shed into extracellular milieu (Pei, D. (1999) J. Biol. Chem. 274, 8925-8932). Here we present evidence that MT5-MMP is shed by a furin-type convertase activity in the trans-Golgi network. Among proteinase inhibitors screened, only decanoyl-Arg-Val-Lys-Arg-chloromethylketone, a known inhibitor for furin-type convertases, blocked the shedding of MT5-MMP in a dose-dependent manner. As expected, decanoyl-Arg-Val-Lys-Arg-chloromethylketone also prevented the activation of MT5-MMP, raising the possibility that the observed shedding could be autolytic. However, an active site mutant devoid of any catalytic activity, is also shed efficiently, thus ruling out the autolytic pathway. The shedding cleavage was subsequently mapped to the stem region immediately upstream of the transmembrane domain, where a cryptic furin recognition site, (545)RRKERR, was recognized. Indeed, MT5-MMP and furin are co-localized in the trans-Golgi network and the shed species could be detected inside the cells. Furthermore, deletion mutations removing this cryptic site prevented MT5-MMP from shedding. The resulting mutants express a gain-of-function phenotype by mediating more robust activation of proMMP-2 than the wild type molecule. Thus, shedding provides a potential mechanism to regulate proteolytic activity of membrane-bound MMPs.
膜相关蛋白的脱落已被认为是一种调节机制,可通过释放膜结合生长因子或去除粘附分子和受体的胞外域来上调或下调细胞功能。我们之前报道过膜型基质金属蛋白酶5(MT5-MMP)的胞外酶会脱落到细胞外环境中(裴,D.(1999年)《生物化学杂志》274卷,8925 - 8932页)。在此我们提供证据表明,MT5-MMP是通过反式高尔基体网络中的弗林蛋白酶样转化酶活性而脱落的。在所筛选的蛋白酶抑制剂中,只有癸酰-精氨酸-缬氨酸-赖氨酸-精氨酸-氯甲基酮,一种已知的弗林蛋白酶样转化酶抑制剂,以剂量依赖的方式阻断了MT5-MMP的脱落。正如预期的那样,癸酰-精氨酸-缬氨酸-赖氨酸-精氨酸-氯甲基酮也阻止了MT5-MMP的激活,这增加了所观察到的脱落可能是自溶的可能性。然而,一个没有任何催化活性的活性位点突变体也能有效地脱落,从而排除了自溶途径。随后,脱落切割位点被定位到跨膜结构域上游紧邻的茎区位置,在那里一个隐蔽的弗林蛋白酶识别位点(545)RRKERR被识别出来。实际上,MT5-MMP和弗林蛋白酶在反式高尔基体网络中共定位,并且在细胞内可以检测到脱落的产物。此外,去除这个隐蔽位点的缺失突变阻止了MT5-MMP的脱落。所产生的突变体通过介导比野生型分子更强的前MMP-2激活而表现出功能获得型表型。因此,脱落提供了一种调节膜结合MMPs蛋白水解活性的潜在机制。